Protective effect of pentoxyfilline in renal toxicity after methotrexate administration

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 9, 2011, Pages 1003-1009

  Asvadi, I ^a   Hajipour, Babak ^b   Asvadi, A ^a   Asl, N A ^c   Roshangar, L ^c   Khodadadi, A ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Kidney; Methotrexate; Pentoxifylline; Rat

Indexed keywords

CREATININE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHOTREXATE; PENTOXIFYLLINE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METHOTREXATE; PENTOXIFYLLINE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054851426     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. TURESSON C, MATTESON EL. Genetics of rheumatoid arthritis. Mayo Clin Proc 2006; 81: 94-101.
2. KOYAMA S, SATO E, TAKAMIZAWA A, TSUKADAIRA A, HANIUDA M, KURAI M, NUMANAMI H, NAGAI S, IZUMI T. Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp Lung Res 2003; 29: 91-111.
3. CETINER M, SENER G, SEHIRU AO, EKŞIOǦLU-DEMIRALP E, ERCAN F, SIRVANCI S, GEDIK N, AKPULAT S, TECIMER T, YEǦEN BC. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol 2005; 209: 39-50.
4. NEUMAN MG, CAMERON RG, HABER JA, KATZ GG, MALKIEWICZ IM, SHEAR NH. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatotoxicity. Clin Biochem 1999; 32: 519-536.
5. KROGER H, HAUSCHILD A, OHDE M, BACHE K, VOIGT WP, THEFELDT W, KRÜGER D. Nicotinamide and methionine reduce the liver toxic effect of methotrexate. Gen Pharmacol 1999; 33: 203-206.
6. BABIAK RM, CAMPELLO AP, CARNIERI EG, OLIVEIRA MB. Methotrexate: pentose cycle and oxidative stress. Cell Biochem Funct 1989; 16: 283-293.
7. MIYAZONO Y, GAO F, HORIE T. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol 2004; 39: 1119-1127.
8. CAPEL ID, LEACH D, DORRELL HM. Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Res 1983; 3: 59-62.
9. UZ E, OKTEM F, YILMAZ HR, UZAR E, OZGÜNER F. The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: Protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2005; 277: 165-170.
10. GOTO E, TOMOJIRI S, OKAMOTO I, TANAKA K. Methotrexate poisoning with acute hepatorenal dysfunction. J Toxicol Clin Toxicol 2001; 39: 101-104.
11. NEUMAN MG, CAMERON RG, HABER JA, KATZ GG, MALKEWCZ IM, SHEAR NH. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatotoxicity. Clin Biochem 1999; 32: 519-536.
12. CETINKAYA A, BULBULOGLU E, KURUTAS EB, KANTARCEKEN B. N-acetylcysteine ameliorates methotrexate-oxidative liver damage in rats. Med Sci Monit 2006; 12: 274-278.
13. DORMANDY JA. Pharmacologic treatment of venous leg ulcers. J Cardiovasc Pharmacol 1995; 25: 61-65.
14. ZABEL P, SCHADE FU, AND SCHLAAK M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993; 187: 447-463.
15. SAMLASKA MAJCP, WINFIELLD EA. Pentoxifylline. J Am Acad Dermatol 1994; 30: 603-621.
16. SCHMIDT J, RATTNER DW, LEWANDROWSKI K, COMPTON CC, MANDAVILLI U, KNOEFEL WT, WARSHAW AL. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44-56.
17. NOYAN T, SAHIN I, SEKEROǦLU MR, DÜLGER H. The serum vitamin C levels in Behcet's disease. Yonsei Med J 2003; 44: 771-778.
18. JAWAN B, GOTO S, PAN TL, LAI CY, LUK HN, ENG HL, LIN YC, CHEN YS, LAN KM, HSIEH SW, WANG CC, CHENG YF, CHEN CL. The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J Surg Res 2003; 110: 378-382.
19. MOSHER B, DEAN R, HARKEMA J, REMICK D, PALMA J, CROCKETT E. Inhibition of chemokines production by kupffer cells decreased hepatic ischemia/reperfusion injury in mice. J Surg Res 2001; 99: 201-210.
20. PAGLIA DE, VALENTINE WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
21. SUN Y, OBERLEY LW, LI Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988 34: 497-500.
22. WASOWICZ W, NEVE J, PERETZ A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522-2526.
23. KAYA H, SEZIK M, OZKAYA O, DITTRICH R, SIEBZEHNRUBL E, WILDT L. Lipid peroxidation at various estradiol concentrations in human circulation during ovarian stimulation with exogenous gonadotropins. Horm Metab Res 2004; 36: 693-695.
24. SUGIYAMA S, HAYAKAWA M, KATO T, HANAKI Y, SHIMIZU K, OZAWA T. Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem Biophys Res Comm 1989; 159: 1121-1127.
25. ZHANG JG, ZHONG LF, ZHANG M, XIA YX. Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 1992; 66: 354-358.
26. JAHOVIC N, CEVIK H, SEHIRU AO, YEǦEN BC, SENER G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34: 282-287.
27. UWAI Y, SAITO H, INUI K. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur J Pharmacol 2000; 409: 31-36.
28. JOHNSTON JA, JOHNSON ES, WALLER PR, VARSHAVSKY A. Methotrexate inhibits proteolysis of dihydrofolate reductase by the N-end rule pathway. J Biol Chem 1995; 270: 8172-8178.
29. KOPYTEK SJ, STANDAERT RF, DYER JC, HU JC. Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate. Chem Biol 2000; 7: 313-321.
30. TOFFOLI G, CORONA G, GIGANTE M, BOIOCCHI M. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. Eur J Cancer 1996; 32: 1591-1597.
31. TABASSUM H, PARVEZ S, PASHA ST, BANERJEE BD, RAISUDDIN S. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol 2010 May 6.
32. SENER G, EKŞIOǦLU-DEMIRALP E, CETINER M, ERCAN F, SIRVANCI S, GEDIK N, YEǦEN BC. L-Carnitine amelio-rates methotrexate-induced oxidative organ injury and inhibits leucocyte death. Cell Biol Toxicol 2006; 22: 47-60.
33. Lu HK, HSIEH CC, HSU JJ, YANG YK, CHOU HN. Preventive effects of Spirulina platensis on skeletal muscle damage under exercise-induced oxidative stress. Eur J Appl Physiol 2006; 98: 220-226.
34. NIKI E, NOGUCHI N, TSUCHIHASHI H, GOTOH N. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr 1995; 62(6 Suppl): 1322-1326.
35. WANG B, PENG L, ZHU L, REN P. Protective effect of total flavonoids from Spirodela polyrrhiza (L.) Schleid on human umbilical vein endothelial cell damage induced by hydrogen peroxide. Colloids Surf B Biointerfaces 2007; 60: 36-40.
36. TERLOUW SA, MASEREEUW R, RUSSEL FG, MILLER DS. Nephrotoxicants Induce Endothelin Release and signaling in renal proximal tubules: Effect on drug efflux. Mol Pharmacol 2001; 59: 1433-1440.
37. WIDEMANN BC, ADAMSON PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006; 11: 694-703.
38. CHAN H, EVANS WE, PRATT CB. Recovery from toxicity associated with high-dose methotrexate: prognostic factors. Cancer Treat Rep1977; 61: 797-804.
39. GREEN MR, CHOWDHARY SA, CHALMERS LM, LOMBARDI KM, CHAMBERLAIN MC. High-dose methotrexate complicated by acute tubular necrosis. Therapy 2006; 3: 495-497.
40. PROUDFOOT AT, KRENZELOK EP, VALE JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol 2004; 42: 1-26.
41. KOLLI VK, ABRAHAM P, ISAAC B, SELVAKUMAR D. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage. Chemotherapy 2009; 55: 83-90.
42. GREEN MR, CHAMBERLAIN MC. Renal dysfunction during and after high-dose methotrexate. Cancer Chemother Pharmacol 2009; 63: 599-604.